pyrazolanthrone has been researched along with formononetin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, DY; Huh, JE; Kang, JW; Lee, JD; Lee, SH; Lee, WI; Nam, D; Park, DS | 1 |
1 other study(ies) available for pyrazolanthrone and formononetin
Article | Year |
---|---|
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
Topics: Chemokine CCL2; Interleukin-6; Isoflavones; JNK Mitogen-Activated Protein Kinases; Macrophages; Mitogen-Activated Protein Kinases; Molecular Structure; NF-kappa B; Osteoblasts; Osteoclasts; p38 Mitogen-Activated Protein Kinases; Phytoestrogens; Proto-Oncogene Proteins c-fos; RANK Ligand; Signal Transduction | 2014 |